FORME FRUSTE KERATOCONUS (FFK)
Clinical trials for FORME FRUSTE KERATOCONUS (FFK) explained in plain language.
Never miss a new study
Get alerted when new FORME FRUSTE KERATOCONUS (FFK) trials appear
Sign up with your email to follow new studies for FORME FRUSTE KERATOCONUS (FFK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for down syndrome vision loss: corneal crosslinking trial launches
Disease control Recruiting nowThis study tests an experimental eye treatment called corneal crosslinking (CXL) for people with Down syndrome who have a condition that makes the front of the eye thin and misshapen, causing blurry vision. The treatment uses vitamin B2 drops and ultraviolet light to strengthen t…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Shorter UV light may be just as effective at halting corneal disease
Disease control Recruiting nowThis study tests a treatment called corneal crosslinking (CXL) for people with keratoconus and similar conditions that cause the cornea to thin and bulge, blurring vision. CXL uses vitamin B2 eye drops and UV light to strengthen the cornea and stop the disease from getting worse.…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 07, 2026 18:40 UTC